Subsequently, Figure 5 B showed that the high expression level of SERPINH1 leads to a low survival rate in PAAD patients, so that during the 75 month, the mortality rate was proximately 100%, and five year- survival rate was 20%. Here, SERPINH1 is linked to pancreatic adenocarcinoma.